KURA logo

Kura Oncology (KURA) EBIT

Annual EBIT

-$170.35 M
-$19.26 M-12.75%

December 31, 2024

Summary

Performance

1-Year Change

-12.75%

3-Year Change

-30.98%

5-Year Change

-172.29%

15-Year Change

-393.1%

KURA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.57%
KURA annual earnings before interest & taxes is higher than 11.57% of companies in Healthcare sector

High & Low

All-time High

-$22.54 M

3-Year Low

-$170.35 M
KURA annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KURA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KURA next annual earnings announcement has not yet been scheduled

OtherKURAprofitabilitymetrics:

Annual Revenue

$53.88 M
KURA annual revenue is $53.88 million

Annual Net Income

-$173.98 M
KURA annual net profit is -$173.98 million

Annual EBITDA

-$169.50 M
KURA annual EBITDA is -$169.50 million

Annual EPS

-$2.02
KURA annual earnings per share is -$2.02

Quarterly EBIT

-$22.45 M
+$31.54 M+58.41%

December 31, 2024

Summary

Performance

3-Month Change

+58.41%

1-Year Change

+47.03%

3-Year Change

+47.03%

5-Year Change

+47.03%

KURA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.68%
KURA quarterly earnings before interest & taxes is higher than 22.68% of companies in Healthcare sector

High & Low

All-time High

-$4.39 M

3-Year Low

-$53.99 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KURA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
KURA next earnings announcement is scheduled for May 2, 2025

OtherKURAprofitabilitymetrics:

Quarterly Revenue

$53.88 M
KURA quarterly revenue is $53.88 million

Quarterly Net Income

-$19.22 M
KURA quarterly net profit is -$19.22 million

Quarterly EBITDA

-$22.45 M
KURA quarterly EBITDA is -$22.45 million

Quarterly EPS

-$0.22
KURA quarterly earnings per share is -$0.22

TTM EBIT

-$176.00 M
+$19.94 M+10.17%

December 31, 2024

Summary

Performance

3-Month Change

+10.17%

1-Year Change

-16.5%

3-Year Change

-16.5%

5-Year Change

-16.5%

KURA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.59%
KURA TTM earnings before interest & taxes is higher than 11.59% of companies in Healthcare sector

High & Low

All-time High

-$4.39 M

3-Year Low

-$195.94 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KURA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
KURA next earnings announcement is scheduled for May 2, 2025

OtherKURAprofitabilitymetrics:

TTM Revenue

$53.88 M
KURA TTM revenue is $53.88 million

TTM Net Income

-$173.98 M
KURA TTM net profit is -$173.98 million

TTM EBITDA

-$175.36 M
KURA TTM EBITDA is -$175.36 million

TTM EPS

-$2.03
KURA TTM earnings per share is -$2.03

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$170.35 M
KURA annual earnings before interest & taxes is -$170.35 million

Annual Revenue

$53.88 M
KURA annual revenue is $53.88 million

Annual Cost Of Goods Sold

-
KURA annual cost of goods sold value is unknown

Annual Operating Expenses

$247.08 M
KURA annual total operating expenses is $247.08 million

KURA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-12.8%+47.0%-16.5%
3 y3 years-31.0%+47.0%-16.5%
5 y5 years-172.3%+47.0%-16.5%

KURA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-31.0%at lowat high+58.4%-35.3%+10.2%
5 y5-year-172.3%at low-26.7%+58.4%-181.3%+10.2%
alltimeall time-655.9%at low-411.7%+58.4%-3911.1%+10.2%

Kura Oncology EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-$170.35 M(+12.8%)
-$22.45 M(-58.4%)
-$176.00 M(-10.2%)
Sep 2024
-
-$53.99 M(+7.1%)
-$195.94 M(+8.8%)
Jun 2024
-
-$50.43 M(+2.7%)
-$180.15 M(+8.2%)
Mar 2024
-
-$49.13 M(+15.9%)
-$166.50 M(+10.2%)
Dec 2023
-$151.08 M(+11.4%)
-$42.39 M(+11.0%)
-$151.08 M(+6.7%)
Sep 2023
-
-$38.20 M(+3.8%)
-$141.57 M(+1.9%)
Jun 2023
-
-$36.79 M(+9.1%)
-$138.88 M(+1.5%)
Mar 2023
-
-$33.70 M(+2.5%)
-$136.86 M(+0.9%)
Dec 2022
-$135.61 M(+4.3%)
-$32.88 M(-7.4%)
-$135.61 M(+0.1%)
Sep 2022
-
-$35.50 M(+2.1%)
-$135.47 M(+1.6%)
Jun 2022
-
-$34.77 M(+7.1%)
-$133.33 M(+1.1%)
Mar 2022
-
-$32.45 M(-0.9%)
-$131.92 M(+1.4%)
Dec 2021
-$130.05 M(+46.0%)
-$32.74 M(-1.9%)
-$130.05 M(+5.5%)
Sep 2021
-
-$33.37 M(+0.0%)
-$123.32 M(+8.6%)
Jun 2021
-
-$33.36 M(+9.1%)
-$113.58 M(+12.9%)
Mar 2021
-
-$30.59 M(+17.6%)
-$100.57 M(+12.9%)
Dec 2020
-$89.05 M(+42.3%)
-$26.02 M(+10.1%)
-$89.05 M(+10.3%)
Sep 2020
-
-$23.62 M(+16.1%)
-$80.75 M(+10.1%)
Jun 2020
-
-$20.34 M(+6.7%)
-$73.38 M(+8.2%)
Mar 2020
-
-$19.07 M(+7.6%)
-$67.83 M(+8.4%)
DateAnnualQuarterlyTTM
Dec 2019
-$62.56 M(+5.2%)
-$17.72 M(+9.1%)
-$62.56 M(+3.0%)
Sep 2019
-
-$16.25 M(+9.8%)
-$60.74 M(+2.5%)
Jun 2019
-
-$14.79 M(+7.2%)
-$59.25 M(+0.5%)
Mar 2019
-
-$13.79 M(-13.3%)
-$58.93 M(-0.9%)
Dec 2018
-$59.48 M(+72.2%)
-$15.90 M(+7.8%)
-$59.48 M(+10.0%)
Sep 2018
-
-$14.76 M(+2.0%)
-$54.07 M(+11.7%)
Jun 2018
-
-$14.47 M(+0.9%)
-$48.42 M(+16.5%)
Mar 2018
-
-$14.35 M(+36.7%)
-$41.56 M(+20.3%)
Dec 2017
-$34.55 M(+28.0%)
-$10.50 M(+15.3%)
-$34.55 M(+10.7%)
Sep 2017
-
-$9.11 M(+19.7%)
-$31.20 M(+8.2%)
Jun 2017
-
-$7.61 M(+3.8%)
-$28.83 M(+4.1%)
Mar 2017
-
-$7.33 M(+2.5%)
-$27.69 M(+2.6%)
Dec 2016
-$26.98 M(+19.7%)
-$7.15 M(+6.3%)
-$26.98 M(+2.6%)
Sep 2016
-
-$6.73 M(+4.0%)
-$26.30 M(+1.2%)
Jun 2016
-
-$6.47 M(-2.3%)
-$26.00 M(+3.5%)
Mar 2016
-
-$6.63 M(+2.3%)
-$25.11 M(+9.8%)
Dec 2015
-$22.54 M
-$6.47 M(+0.7%)
-$22.88 M(+39.5%)
Sep 2015
-
-$6.43 M(+15.1%)
-$16.40 M(+64.5%)
Jun 2015
-
-$5.58 M(+27.3%)
-$9.97 M(+127.3%)
Mar 2015
-
-$4.39 M
-$4.39 M

FAQ

  • What is Kura Oncology annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Kura Oncology?
  • What is Kura Oncology annual EBIT year-on-year change?
  • What is Kura Oncology quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Kura Oncology?
  • What is Kura Oncology quarterly EBIT year-on-year change?
  • What is Kura Oncology TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Kura Oncology?
  • What is Kura Oncology TTM EBIT year-on-year change?

What is Kura Oncology annual earnings before interest & taxes?

The current annual EBIT of KURA is -$170.35 M

What is the all time high annual EBIT for Kura Oncology?

Kura Oncology all-time high annual earnings before interest & taxes is -$22.54 M

What is Kura Oncology annual EBIT year-on-year change?

Over the past year, KURA annual earnings before interest & taxes has changed by -$19.26 M (-12.75%)

What is Kura Oncology quarterly earnings before interest & taxes?

The current quarterly EBIT of KURA is -$22.45 M

What is the all time high quarterly EBIT for Kura Oncology?

Kura Oncology all-time high quarterly earnings before interest & taxes is -$4.39 M

What is Kura Oncology quarterly EBIT year-on-year change?

Over the past year, KURA quarterly earnings before interest & taxes has changed by +$19.94 M (+47.03%)

What is Kura Oncology TTM earnings before interest & taxes?

The current TTM EBIT of KURA is -$176.00 M

What is the all time high TTM EBIT for Kura Oncology?

Kura Oncology all-time high TTM earnings before interest & taxes is -$4.39 M

What is Kura Oncology TTM EBIT year-on-year change?

Over the past year, KURA TTM earnings before interest & taxes has changed by -$24.92 M (-16.50%)